Nonaspirin NSAIDs and contralateral breast cancer risk

Keyphrases

• Non-steroidal Anti-inflammatory Drugs (NSAIDs) 100%
• Contralateral Breast Cancer Risk 100%
• Contralateral Breast Cancer 75%
• Confidence Interval 50%
• Hazard Ratio 50%
• Cyclooxygenase-2 37%
• Breast Cancer Patients 25%
• Breast Cancer 25%
• Cox Proportional Hazards Model 12%
• Nationwide Registry 12%
• Risk Reduction 12%
• National Cohort Study 12%
• Time-dependent Covariates 12%
• Adjusted Hazard Ratio 12%
• Clinical Database 12%
• Non-selective 12%
• Confounding Variables 12%
• Breast Cancer Progression 12%
• Cancer-associated 12%
• Cyclooxygenase-2 Enzyme 12%

Medicine and Dentistry

• Nonsteroid Antiinflammatory Agent 100%
• Contralateral 100%
• Breast Cancer 100%
• Hazard Ratio 41%
• Drug Use 33%
• Cyclooxygenase 2 33%
• Cohort Analysis 8%
• Proportional Hazards Model 8%
• Enzymes 8%
• Median Follow Up 8%

Pharmacology, Toxicology and Pharmaceutical Science

• Breast Cancer 100%
• Non-Steroidal Anti-Inflammatory Drug 100%
• Cyclooxygenase 2 33%
• Cohort Study 8%
• Enzymes 8%